Aaron Bartlone
Fortune : 3 M $ au 31/08/2026
Fortune : 3 M $ au 31/08/2026
Mr. Aaron Bartlone is a Chief Operating Officer at Cybin, Inc. Mr. Bartlone was previously employed as a Various Director by Eli Lilly & Co., a President & Managing Director by Ab Dynamix LLC, and a Chief Quality, Patient Safety, HSE & Risk Officer by UCB, Inc. He received his undergraduate degree from Youngstown State University and a graduate degree from the University of Notre Dame.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
HELUS PHARMA INC. 0,36% | 02/09/2026 | 225 154 ( 0,36% ) | 3 M $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CYBIN INC. | Directeur des opérations | 01/07/2023 |
| Sociétés | Poste | Fin |
|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/01/2006 |
Ab Dynamix LLC | Directeur Général | - |
UCB, Inc.
UCB, Inc. Financial ConglomeratesFinance Provides financial services | President | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
University of Notre Dame
University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Youngstown State University
Youngstown State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCB, Inc.
UCB, Inc. Financial ConglomeratesFinance Provides financial services | Finance |
Cybin, Inc.
Cybin, Inc. Pharmaceuticals: MajorHealth Technology Manufactures neurological pharmaceuticals | Health Technology |
Ab Dynamix LLC |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national